CitiusTech Makes Strategic Leadership Changes for Future Growth and Innovation

In a significant move aimed at enhancing its leadership structure, CitiusTech, a prominent digital and enterprise AI company dedicated to the healthcare and life sciences sectors, has appointed Dhaval Shah as its Acting Chief Executive Officer and Shyam Karunakaran as President. This transition is set against a backdrop of robust business momentum, particularly focusing on the adoption of artificial intelligence in the healthcare domain.

Elevated Leadership Roles

The appointments, announced on August 17, 2026, reflect a well-thought-out succession plan, further demonstrating CitiusTech's confidence in its leadership team as the organization gears up for the next phase of its growth journey. Dhaval Shah, who previously served as the Chief Business Officer for MedTech and Life Sciences markets, steps into the role of Acting CEO, while Shyam Karunakaran, who was the Chief Business Officer for Healthcare Payer Platforms, now takes on the role of President, overseeing a myriad of functions that encompass enterprise strategy and market execution.

Dr. William Winkenwerder Jr., the Chairman of CitiusTech, emphasized the crucial role that both leaders have played in the company’s evolution, mentioning their long-standing presence and contributions since its early days. Together, Shah and Karunakaran command a notable portion of CitiusTech's operations, driving over 80% of its business.

Focus on AI Transformation

The leadership change comes at a pivotal time when CitiusTech is leveraging its deep-rooted expertise in healthcare to accelerate the adoption of AI technologies within the industry. The company recently reported strong growth figures for FY26, which positioned it among the top quartile of technology service providers. This upward trajectory is expected to continue into FY27 as client demand for AI-driven healthcare solutions surges.

Shah expressed appreciation for the solid foundation laid by his predecessor, Rajan Kohli, who is transitioning from his role by the end of August 2026 to pursue other opportunities. In his acceptance speech, Shah stated, “Our vision to accelerate healthcare intelligence is well and truly underway, and we intend to integrate intelligence into the core decision-making of healthcare organizations.” This outlook indicates a clear path forward, focusing on establishing CitiusTech as a frontrunner in the healthcare AI service sector.

Investment in Future Growth

Karunakaran, with 17 years of experience at CitiusTech, is also poised to bring his strategic approach to the broader organizational framework. He is committed to pushing the company's mission forward as the healthcare landscape evolves around AI technologies. He remarked, “Between Dhaval and me, we bring over 36 years of experience at CitiusTech, and we are excited to lead the company through its next phase.”

Amidst announcements of leadership changes, Rajan Kohli expressed his satisfaction regarding the partnerships forged within the healthcare ecosystem while collaborating with a talented team. He underscored how their joint efforts have enhanced the company’s brand visibility and built a strong foundation for AI solutions.

Conclusion

CitiusTech continues to showcase its commitment to healthcare innovation through these strategic leadership appointments, reinforcing its position as a leader in healthcare technology. As the industry swings toward AI-enabled solutions, the insights and experience from Shah and Karunakaran promise to propel CitiusTech into the future of healthcare.

As CitiusTech evolves and expands its service offerings, the leadership’s vision prioritizes integration, intelligence, and innovation within healthcare systems on a global scale. The next chapter of growth at CitiusTech aims to not just adapt to change but actively shape the future of health technology.